title: US judge fines Johnson & Johnson $1.1bn for misleading marketing of risperidone.
authors.forename: Janice Hopkins
authors.initials: JH
authors.lastname: Tanne
mesh_terms: D000329:Advertising / Q000331:legislation & jurisprudence; D014150:Antipsychotic Agents / Q000191:economics / Q000627:therapeutic use; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D007603:Jurisprudence; D040541:Marketing / Q000331:legislation & jurisprudence / Q000379:methods; D011358:Product Surveillance, Postmarketing; D018967:Risperidone / Q000191:economics / Q000627:therapeutic use; D014481:United States
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone